Previous Section
Clinical Trials
1. A phase I trial of surgery, Gliadel wafer implantation, and immediate postoperative carboplatin in combination with radiation therapy for primary anaplastic astrocytoma or glioblastoma multiforme.
- Author
- Limentani, Steven A; Asher, Anthony; Heafner, Michael; Kim JW; Fraser, Robert;
- Institution
- Carolinas Hematology-Oncology Associates, 1100 South Tryon Street, Charlotte, North Carolina 28203, USA. steven.limentani@carolinashealthcare.org
- Journal
- J Neurooncol. 2005 May;72(3):241-4.
- Abstract URL
- Click here to view abstract
2. A Phase II trial of paclitaxel and topotecan with filgrastim in patients with recurrent or refractory glioblastoma multiforme or anaplastic astrocytoma.
- Author
- Pipas JM; Meyer LP; Rhodes CH; Cromwell LD; McDonnell CE; Kingman LS; Rigas JR; Fadul CE;
- Institution
- Neuro-Oncology Program, Dartmouth-Hitchcock Medical Center, Norris Cotton Cancer Center, 1 Medical Center Drive, New Hampshire, Lebanon, NH 03756, USA. j.marc.pipas@hitchcock.org
- Journal
- J Neurooncol. 2005 Feb;71(3):301-5.
- Abstract URL
- Click here to view abstract
3. PCV chemotherapy for recurrent glioblastoma.
- Author
- Schmidt F; Fischer J; Herrlinger U; Dietz K; Dichgans J; Weller M;
- Institution
- Department of General Neurology, Hertie Institute for Clinical Brain Research, University of Tuebingen, Medical School, Tuebingen, Germany. friederike.schmidt@uni-tuebingen.de
- Journal
- Neurology. 2006 Feb 28;66(4):587-9.
- Abstract URL
- Click here to view abstract
4. Phase 2 trial of radiation plus high-dose tamoxifen for glioblastoma multiforme: RTOG protocol BR-0021.
- Author
- Robins HI; Won M; Seiferheld WF; Schultz CJ; Choucair AK; Brachman DG; Demas WF; Mehta MP;
- Institution
- Comprehensive Cancer Center, University of Wisconsin, Madison, WI 53792-6164, USA. hirobins@wisc.edu
- Journal
- Neuro-oncol. 2006 Jan;8(1):47-52.
- Abstract URL
- Click here to view abstract
5. Adding chloroquine to conventional treatment for glioblastoma multiforme: a randomized, double-blind, placebo-controlled trial.
- Author
- Sotelo J; Briceno E; Lopez-Gonzalez MA; Sotelo J; Briceno E; Lopez-Gonzalez MA;
- Institution
- National Institute of Neurology and Neurosurgery of Mexico, Mexico City, Mexico. jsotelo@servidor.unam.mx
- Journal
- Ann Intern Med. 2006 Mar 7;144(5):337-43.
- Abstract URL
- Click here to view abstract
6. Phase III trial of carmustine and cisplatin compared with carmustine alone and standard radiation therapy or accelerated radiation therapy in patients with glioblastoma multiforme: North Central Cancer Treatment Group 93-72-52 and Southwest Oncology Group 9503 Trials.
- Author
- Buckner JC; Ballman KV; Michalak JC; Burton GV; Cascino TL; Schomberg PJ; Hawkins RB; Scheithauer BW; Sandler HM; Marks RS; O'Fallon JR; Buckner JC; Ballman KV; Michalak JC; Burton GV; Cascino TL; Schomberg PJ; Hawkins RB; Scheithauer BW; Sandler HM; Marks RS; O'Fallon JR;
- Institution
- Mayo Clinic and Mayo Foundation, Rochester, MN 55905, USA. buckner.jan@mayo.edu
- Journal
- J Clin Oncol. 2006 Aug 20;24(24):3871-9.
- Abstract URL
- Click here to view abstract
7. Outcome and prognostic factors in cerebellar glioblastoma multiforme in adults: a retrospective study from the Rare Cancer Network.
- Author
- Weber DC; Miller RC; Villa S; Hanssens P; Baumert BG; Castadot P; Varlet P; Abacioglu U; Igdem S; Szutowicz E; Nishioka H; Hofer S; Rutz HP; Ozsahin M; Taghian A; Mirimanoff RO; Weber DC; Miller RC; Villa S; Hanssens P; Baumert BG; Castadot P; Varlet P; Abacioglu U; Igdem S; Szutowicz E; Nishioka H; Hofer S; Rutz HP; Ozsahin M; Taghian A; Mirimanoff RO; Weber DC; Miller RC; Villa S; Hanssens P; Baumert BG; Castadot P; Varlet P; Abacioglu U; Igdem S; Szutowicz E; Nishioka H; Hofer S; Rutz HP; Ozsahin M; Taghian A; Mirimanoff RO;
- Institution
- University Hospital of Geneva, Geneva, Switzerland. damien.weber@hcuge.ch
- Journal
- Int J Radiat Oncol Biol Phys. 2006 Sep 1;66(1):179-86. Epub 2006 Jul 11.
- Abstract URL
- Click here to view abstract
8. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.
- Author
- Stupp, Roger; Mason, Warren P; van den Bent, Martin J; Weller, Michael; Fisher, Barbara; Taphoorn, Martin J B; Belanger, Karl; Brandes, Alba A; Marosi, Christine; Bogdahn, Ulrich; Curschmann, Jurgen; Janzer, Robert C; Ludwin, Samuel K; Gorlia, Thierry; Allgeier, Anouk; Lacombe, Denis; Cairncross, J Gregory; Eisenhauer, Elizabeth; Mirimanoff, Rene O;
- Institution
- Multidisciplinary Oncology Center, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland. roger.stupp@chuv.hospvd.ch
- Journal
- N Engl J Med. 2005 Mar 10;352(10):987-96.
- Abstract URL
- Click here to view abstract
9. Randomized phase II study of temozolomide and radiotherapy compared with radiotherapy alone in newly diagnosed glioblastoma multiforme.
- Author
- Athanassiou, Helen; Synodinou, Maria; Maragoudakis, Evagelos; Paraskevaidis, Mihalis; Verigos, Cosmas; Misailidou, Despina; Antonadou, Dosia; Saris, George; Beroukas, Konstantinos; Karageorgis, Pantelis;
- Institution
- Radiation Oncology, St Savas Cancer Hospital, 79 Zimbrakaki St, 10445 Athens, Greece. elathanasiou@yahoo.com
- Journal
- J Clin Oncol. 2005 Apr 1;23(10):2372-7.
- Abstract URL
- Click here to view abstract
10. Phase II trial of tipifarnib in patients with recurrent malignant glioma either receiving or not receiving enzyme-inducing antiepileptic drugs: a North American Brain Tumor Consortium Study.
- Author
- Cloughesy TF; Wen PY; Robins HI; Chang SM; Groves MD; Fink KL; Junck L; Schiff D; Abrey L; Gilbert MR; Lieberman F; Kuhn J; DeAngelis LM; Mehta M; Raizer JJ; Yung WK; Aldape K; Wright J; Lamborn KR; Prados MD;
- Institution
- UCLA Neuro-Oncology Program, David Geffen School of Medicine at UCLA, University of California, Los Angeles, Los Angeles, CA 90095, USA. tcloughe@ucla.edu
- Journal
- J Clin Oncol. 2006 Aug 1;24(22):3651-6.
- Abstract URL
- Click here to view abstract
Next: Radiation Therapy
